Company news
Vivoryon Therapeutics N.V. news in 2026
Vivoryon Therapeutics N.V.'s news releases, calls and decks from 2026, newest first.
Vivoryon Therapeutics N.V. Reports Q3 2026 Financial Results and Provides Business Update
November 5, 2026
Vivoryon Therapeutics N.V. Reports Outcome of 2026 Annual General Meeting
September 29, 2026
Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026
August 18, 2026
Vivoryon Therapeutics N.V. Reports H1 2026 Financial Results and Provides Business Update
August 6, 2026
Vivoryon Therapeutics N.V. to Report H1 2026 Financial Results and Business Updates on August 6, 2026, Annual General Meeting Planned for End of September 2026
July 23, 2026
Vivoryon Therapeutics N.V. to Report H1 2026 Financial Results and Business Updates on August 6, 2026; Annual General Meeting Planned for End of September 2026
July 22, 2026
Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update
June 11, 2026
Vivoryon Therapeutics N.V. to Report Q1 2026 Financial Results on June 11, 2026
June 8, 2026
Vivoryon Therapeutics N.V. Reports Full Year 2025 Financial Results and Provides Business Update
April 23, 2026
Vivoryon Therapeutics N.V. to Report Full Year 2025 Financial Results and Business Updates on April 23, 2026
April 15, 2026
Vivoryon Therapeutics N.V. to Attend Upcoming Investor Conference
April 9, 2026
Vivoryon Therapeutics N.V. Provides Update on Growing Body of Evidence Validating Glutaminyl Cyclases as Promising Targets in DKD at World Congress of Nephrology
March 28, 2026
Vivoryon Therapeutics N.V. to Attend and Present in Upcoming Conferences
January 7, 2026
Calls in 2026
Decks in 2026
- Shareholder Meeting (September 2026)
Shareholder meeting · 23 slides · Sep 29, 2026
- Investor Presentation (August 2026)
Investor deck · 25 slides · August 2026
- Investor Presentation (May 2026)
Investor deck · 25 slides · May 2026
- Investor Presentation (March 2026)
Investor deck · 24 slides · Mar 11, 2026